Ramm Pharma Announces Application for Management Cease Trade Order
13 févr. 2023 16h31 HE
|
RAMM Pharma Corp.
TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”) announces today that it has made an application to relevant Canadian securities regulators to approve a...
RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer
09 déc. 2022 16h30 HE
|
RAMM Pharma Corp.
TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce the appointment of José Roldan as...
RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland
06 sept. 2022 09h54 HE
|
RAMM Pharma Corp.
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of...
RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid
17 août 2022 07h32 HE
|
RAMM Pharma Corp.
TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course...
Ramm Pharma Announces Cease Trade Order
28 févr. 2022 18h51 HE
|
RAMM Pharma Corp.
TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”). On February 22, 2022, the Company announced that, for reasons set out in its news release of February 22,...
Ramm Pharma Announces Application for Management Cease Trade Order
22 févr. 2022 17h30 HE
|
RAMM Pharma Corp.
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”) announces today that it has made an application to relevant Canadian securities regulators to approve a...
RAMM Provides Update on European Operations
22 févr. 2022 08h40 HE
|
RAMM Pharma Corp.
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations
05 janv. 2022 07h30 HE
|
RAMM Pharma Corp.
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp., including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
RAMM Pharma Corp. Welcomes Proposed Legalization of Recreational Cannabis in Germany
01 déc. 2021 09h03 HE
|
RAMM Pharma Corp.
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
RAMM Pharma Announces Resignation of Director
15 sept. 2021 16h30 HE
|
RAMM Pharma Corp.
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and...